Chester County News and Community Website
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) recently disclosed their financial results for the first quarter of 2024, while also providing an update on their business operations. …
Orchestra BioMed Unveils Q1 2024 Financial Results, Advances Pivotal Studies on Innovative Medical Therapies Read More
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) this week announced promising developments in its first quarter financial and operational update for 2024. The company reported progress on several …
Helius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke Program Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) this week disclosed its first-quarter financial outcomes for 2024, showcasing significant growth and strategic advancements. The company, known for its innovative contract manufacturing …
NEXGEL Reports Double-Digit Revenue Growth Amid Strategic Expansion Read More
LANGHORNE, PA — Biopharmaceutical company Savara Inc. (Nasdaq: SVRA) disclosed its financial outcomes for the first quarter ended March 31, 2024, while casting an optimistic glance towards its pipeline’s progress …
Savara Inc. Eyes Future Growth with Ongoing IMPALA-2 Trial and Strategic Investments Read More
NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) recently disclosed its financial outcomes for the first quarter ended March 31, 2024, revealing a slight downturn in revenues but maintaining a …
EPAM Systems Reports First Quarter Results and Adjusts Full-Year Outlook Amid Challenging Demand Read More LAHASKA, PA — Specialty Care Management (SCM) recently announced a strategic alliance with Springbuk, a leading health intelligence platform that serves employers and benefits advisors. This partnership aims to leverage …
Specialty Care Management Partners with Springbuk to Tackle High-Cost Dialysis Claims Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) is set to announce its financial outcomes for the first quarter of 2024 on Monday, May 13, after the market closure.
Helius Medical Technologies to Unveil Q1 2024 Results and Discuss PoNS® U.S. Commercialization Read More
NEWTOWN, PA — Traws Pharma, Inc. announced this week the completion of dosing in the first cohort of a groundbreaking Phase 1 study on travatrelvir (TRX01), an innovative oral protease …
Traws Pharma Advances COVID-19 Treatment into First Human Trials Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a clinical-stage biopharmaceutical company, has successfully navigated back to compliance with Nasdaq’s minimum bid price requirement, a crucial step for maintaining its …
Windtree Therapeutics Regains Nasdaq Compliance with Minimum Bid Price Requirement Read More
SOUTHAMPTON, PA — Drumming up impressive figures amidst challenging financial landscapes, Quaint Oak Bancorp, Inc., in the first quarter of 2024, reveled in a notable 55.1% surge in their net …
Quaint Oak Bancorp Reports Stellar Growth in Q1 2024 amid Subsidiary Divestments Read More